152 related articles for article (PubMed ID: 32553781)
1. Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors.
Sakurai Y; Ichinoe M; Yoshida K; Nakazato Y; Saito S; Satoh M; Nakada N; Sanoyama I; Umezawa A; Numata Y; Shi-Xu J; Ichihara M; Takahashi M; Murakumo Y
Cancer Lett; 2020 Oct; 489():100-110. PubMed ID: 32553781
[TBL] [Abstract][Full Text] [Related]
2. Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells.
Niimi K; Murakumo Y; Watanabe N; Kato T; Mii S; Enomoto A; Asai M; Asai N; Yamamoto E; Kajiyama H; Shibata K; Kikkawa F; Takahashi M
Cancer Sci; 2014 May; 105(5):545-52. PubMed ID: 24597627
[TBL] [Abstract][Full Text] [Related]
3. MAD2γ, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors.
López-Saavedra A; Ramírez-Otero M; Díaz-Chávez J; Cáceres-Gutiérrez R; Justo-Garrido M; Andonegui MA; Mendoza J; Downie-Ruíz Á; Cortés-González C; Reynoso N; Castro-Hernández C; Domínguez-Gómez G; Santibáñez M; Fabián-Morales E; Pruefer F; Luna-Maldonado F; González-Barrios R; Herrera LA
Cell Cycle; 2016 Aug; 15(15):2066-76. PubMed ID: 27315568
[TBL] [Abstract][Full Text] [Related]
4. Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor.
Kitayama S; Ikeda K; Sato W; Takeshita H; Kawakami S; Inoue S; Horie K
Sci Rep; 2022 Nov; 12(1):18423. PubMed ID: 36319719
[TBL] [Abstract][Full Text] [Related]
5. Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells.
Fung MK; Cheung HW; Ling MT; Cheung AL; Wong YC; Wang X
Br J Cancer; 2006 Aug; 95(4):475-84. PubMed ID: 16880791
[TBL] [Abstract][Full Text] [Related]
6. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic sensitivity of testicular germ cell tumors under hypoxic conditions is negatively regulated by SENP1-controlled sumoylation of OCT4.
Wu YC; Ling TY; Lu SH; Kuo HC; Ho HN; Yeh SD; Shen CN; Huang YH
Cancer Res; 2012 Oct; 72(19):4963-73. PubMed ID: 23002208
[TBL] [Abstract][Full Text] [Related]
8. A missense mutation in Rev7 disrupts formation of Polζ, impairing mouse development and repair of genotoxic agent-induced DNA lesions.
Khalaj M; Abbasi A; Yamanishi H; Akiyama K; Wakitani S; Kikuchi S; Hirose M; Yuzuriha M; Magari M; Degheidy HA; Abe K; Ogura A; Hashimoto H; Kunieda T
J Biol Chem; 2014 Feb; 289(6):3811-24. PubMed ID: 24356953
[TBL] [Abstract][Full Text] [Related]
9. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
Nitzsche B; Gloesenkamp C; Schrader M; Hoffmann B; Zengerling F; Balabanov S; Honecker F; Höpfner M
Br J Cancer; 2012 Nov; 107(11):1853-63. PubMed ID: 23169338
[TBL] [Abstract][Full Text] [Related]
11. Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours.
Harpelunde Poulsen K; Nielsen JE; Grønkær Toft B; Joensen UN; Rasmussen LJ; Blomberg Jensen M; Mitchell RT; Juul A; Rajpert-De Meyts E; Jørgensen A
BMC Cancer; 2020 Apr; 20(1):349. PubMed ID: 32326899
[TBL] [Abstract][Full Text] [Related]
12. Rev7 loss alters cisplatin response and increases drug efficacy in chemotherapy-resistant lung cancer.
Vassel FM; Bian K; Walker GC; Hemann MT
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28922-28924. PubMed ID: 33144509
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
[TBL] [Abstract][Full Text] [Related]
14. PCPH expression is an early event in the development of testicular germ cell tumors.
Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V
Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363
[TBL] [Abstract][Full Text] [Related]
15. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
[TBL] [Abstract][Full Text] [Related]
16. The REV7 subunit of DNA polymerase ζ is essential for primordial germ cell maintenance in the mouse.
Watanabe N; Mii S; Asai N; Asai M; Niimi K; Ushida K; Kato T; Enomoto A; Ishii H; Takahashi M; Murakumo Y
J Biol Chem; 2013 Apr; 288(15):10459-71. PubMed ID: 23463509
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of REV7 correlates with progression of malignant melanoma.
Hoshino A; Nakayama C; Jiang SX; Sakurai Y; Kato T; Numata Y; Umezawa A; Ichinoe M; Murakumo Y
Pathol Int; 2022 Jan; 72(1):14-24. PubMed ID: 34637584
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.
Schmidtova S; Kalavska K; Kucerova L
Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297
[TBL] [Abstract][Full Text] [Related]
19. Rev7, the regulatory subunit of Polζ, undergoes UV-induced and Cul4-dependent degradation.
Bhat A; Qin Z; Wang G; Chen W; Xiao W
FEBS J; 2017 Jun; 284(12):1790-1803. PubMed ID: 28440919
[TBL] [Abstract][Full Text] [Related]
20. REV7 Monomer Is Unable to Participate in Double Strand Break Repair and Translesion Synthesis but Suppresses Mitotic Errors.
Vassel FM; Laverty DJ; Bian K; Piett CG; Hemann MT; Walker GC; Nagel ZD
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
